Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Roche reports new adenosine A2A receptor ligands and use for Parkinson's, depression

Feb. 3, 2005

New antiinfective agents from Dr. Reddy's

Feb. 3, 2005

Guilford discloses new PARP inhibitors

Feb. 2, 2005

Calcium channel blockers emerge from NeuroMed R&D

Feb. 2, 2005

Integrin antagonists in early development at Genentech

Feb. 2, 2005

OSI scientists develop new glycogen phosphorylase inhibitors

Feb. 2, 2005

Ajinomoto patents TRPV receptor ligands for treatment of pain

Feb. 2, 2005

New compounds for immune-mediated diseases designed at Merck

Feb. 2, 2005

5HT-7 receptor modulators and their use in IBS claimed by Ajinomoto

Feb. 1, 2005

New DPP-IV inhibitors discovered at Syrrx

Feb. 1, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...